Potential drug interactions among cancer patients using oral cytostatic drugs: a prevalence study
Not Applicable
Completed
- Conditions
- Cancer
- Registration Number
- ISRCTN01739090
- Lead Sponsor
- Maastricht University Medical Centre (Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
All ambulatory patients with the diagnosis solid tumour or a malignant haematological disease who are receiving oral anticancer therapy
Exclusion Criteria
1. The use of experimental trial agents
2. Age <18 years
3. The use of oral anticancer drugs for non-oncological diseases
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate the prevalence of DDIs among ambulatory cancer patients on oral anticancer treatment
- Secondary Outcome Measures
Name Time Method To gain more insight into possible determinants for the occurrence of these DDIs